Skip to main content
Latest news
Browse specialties
Breast cancer Genitourinary cancers Lung & thoracic cancers
In focus
Next-generation sequencing: Emerging biomarkers in thyroid and NSCLCs ctDNA and bladder cancer: Current understanding and beyond ROS1 fusion-positive NSCLC NSCLC driver mutations: Discussing the importance of RET, ALK and ROS1 alterations in NSCLC Early-stage NSCLC management: Surgery, targeted treatment and immunotherapy ALK fusion-positive NSCLC: International approaches to management RET fusion-positive NSCLC: Informing on the use of pralsetinib for patients with RET fusion-positive, advanced NSCLC COVID-19 & cancer
Conferences
SABCS 2022 ESMO 2022 2022 ASCO Annual Meeting
About us
Medicine Matters Oncology
EXTENDED SEARCH
Top

25-08-2017 | Sarcoma | Article

Clinical features and outcomes of extramedullary myeloid sarcoma in the United States: analysis using a national data set

Journal: Blood Cancer Journal

Authors: G Goyal, A C Bartley, M M Patnaik, , A Al-Kali, R S Go

Authors: G Goyal, A C Bartley, M M Patnaik, M R Litzow, A Al-Kali, R S Go

Publisher: Nature Publishing Group UK

Login to get access

Abstract

Blood Cancer J 2017; 7: e592. doi:10.1038/bcj.2017.79

Literature
1.
Dores GM, Devesa SS, Curtis RE, Linet MS, Morton LM . Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007. Blood 2012; 119: 34–43.CrossRef
2.
Neiman RS, Barcos M, Berard C, Bonner H, Mann R, Rydell RE et al. Granulocytic sarcoma: a clinicopathologic study of 61 biopsied cases. Cancer 1981; 48: 1426–1437.CrossRef
3.
Paydas S, Zorludemir S, Ergin M . Granulocytic sarcoma: 32 cases and review of the literature. Leuk Lymphoma 2006; 47: 2527–2541.CrossRef
4.
Pileri SA, Ascani S, Cox MC, Campidelli C, Bacci F, Piccioli M et al. Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. Leukemia 2007; 21: 340–350.CrossRef
5.
Shinagare AB, Krajewski KM, Hornick JL, Zukotynski K, Kurra V, Jagannathan JP et al. MRI for evaluation of myeloid sarcoma in adults: a single-institution 10-year experience. Am J Roentgenol 2012; 199: 1193–1198.CrossRef
6.
National Comprehensive Cancer Network Acute myeloid leukemia (Version 1.2017) (accessed 28 April, 2017). Available from: https://​www.​nccn.​org/​professionals/​physician_​gls/​pdf/​aml.​pdf.
7.
American College of Surgeons: National Cancer Data Base. Available from: https://​www.​facs.​org/​quality%20​programs/​cancer/​ncdbaccessed 28 April 2017.
8.
Movassaghian M, Brunner AM, Blonquist TM, Sadrzadeh H, Bhatia A, Perry AM et al. Presentation and outcomes among patients with isolated myeloid sarcoma: a surveillance, epidemiology, and end results database analysis. Leuk Lymphoma 2015; 56: 1698–1703.CrossRef
9.
Imrie KR, Kovacs MJ, Selby D, Lipton J, Patterson BJ, Pantalony D et al. Isolated chloroma: the effect of early antileukemic therapy. Ann Intern Med 1995; 123: 351–353.CrossRef
10.
Bakst RL, Tallman MS, Douer D, Yahalom J . How I treat extramedullary acute myeloid leukemia. Blood 2011; 118: 3785–3793.CrossRef
11.
Meis JM, Butler JJ, Osborne BM, Manning JT . Granulocytic sarcoma in nonleukemic patients. Cancer 1986; 58: 2697–2709.CrossRef
12.
Master S, Mansour R, Devarakonda SS, Shi Z, Mills G, Shi R . Predictors of survival in acute myeloid leukemia by treatment modality. Anticancer Res 2016; 36: 1719–1727.CrossRef